Full metadata record

DC Field Value Language
dc.contributor.authorKang, Gum-Yong-
dc.contributor.authorLee, Eung-Ryoung-
dc.contributor.authorKim, Jung-Hyun-
dc.contributor.authorJung, Jin Woo-
dc.contributor.authorLim, Jun-
dc.contributor.authorKim, Sang Kyung-
dc.contributor.authorCho, Ssang-Goo-
dc.contributor.authorKim, Kwang Pyo-
dc.date.accessioned2024-01-20T21:05:40Z-
dc.date.available2024-01-20T21:05:40Z-
dc.date.created2021-09-03-
dc.date.issued2009-06-02-
dc.identifier.issn0014-2999-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/132402-
dc.description.abstractThe molecular mechanisms underlying the kaempferol-induced cell death have not yet been fully explained. To investigate the role of kaempferol, widely distributed in foods, in tumor progression, human breast cancer cell line, MCF-7, was treated with kaempferol. Apoptosis was indicated by the accumulation of a sub-G1 population, as well as the appearance of 4'-6-diamidino-2-phenylindole (DAPI)-stained apoptotic nuclei in the MCF-7 cells after the administration of kaempferol. Western blot analysis showed cleavage of Poly (ADPribose) polymerase (PARP), caspase-7, Bax. and caspase-9 indicating that the intracellular pathway of apoptosis was involved. Kaempferol also downregulated the expression of polo-like kinase 1 (PLK-1), which has been reported to regulate mitotic progression and to be upregulated in several human tumors. Taken together, these findings indicate that kaempferol-induced apoptosis by initiation of intrinsic caspase cascade and downregulation of PLK-1 expression. (C) 2009 Elsevier B.V. All rights reserved.-
dc.languageEnglish-
dc.publisherELSEVIER SCIENCE BV-
dc.subjectPOLO-LIKE-KINASE-
dc.subjectCANCER-CELLS-
dc.subjectPROGNOSTIC-SIGNIFICANCE-
dc.subjectGROWTH-INHIBITION-
dc.subjectPROSTATE-CANCER-
dc.subjectPROTEIN-KINASE-
dc.subjectLUNG-CANCER-
dc.subjectFLAVONOIDS-
dc.subjectPROLIFERATION-
dc.subjectKERATINOCYTES-
dc.titleDownregulation of PLK-1 expression in kaempferol-induced apoptosis of MCF-7 cells-
dc.typeArticle-
dc.identifier.doi10.1016/j.ejphar.2009.03.068-
dc.description.journalClass1-
dc.identifier.bibliographicCitationEUROPEAN JOURNAL OF PHARMACOLOGY, v.611, no.1-3, pp.17 - 21-
dc.citation.titleEUROPEAN JOURNAL OF PHARMACOLOGY-
dc.citation.volume611-
dc.citation.number1-3-
dc.citation.startPage17-
dc.citation.endPage21-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000266539600003-
dc.identifier.scopusid2-s2.0-67349252446-
dc.relation.journalWebOfScienceCategoryPharmacology & Pharmacy-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.type.docTypeArticle-
dc.subject.keywordPlusPOLO-LIKE-KINASE-
dc.subject.keywordPlusCANCER-CELLS-
dc.subject.keywordPlusPROGNOSTIC-SIGNIFICANCE-
dc.subject.keywordPlusGROWTH-INHIBITION-
dc.subject.keywordPlusPROSTATE-CANCER-
dc.subject.keywordPlusPROTEIN-KINASE-
dc.subject.keywordPlusLUNG-CANCER-
dc.subject.keywordPlusFLAVONOIDS-
dc.subject.keywordPlusPROLIFERATION-
dc.subject.keywordPlusKERATINOCYTES-
dc.subject.keywordAuthorApoptosis-
dc.subject.keywordAuthorKaempferol-
dc.subject.keywordAuthorPolo-like kinase 1-
dc.subject.keywordAuthorCaspase-
dc.subject.keywordAuthorPoly-ADP-ribose polymerase-
Appears in Collections:
KIST Article > 2009
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE